Holding(s) in Company

1

Identity of the issuer or the underlying issuer of existing shares to which the voting rights are attached

Hikma Pharmaceuticals PLC

2

Reason for the notification

An acquisition or disposal of voting rights

Yes

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issues to which voting rights are attached

No

An event changing the breakdown of voting rights

No

Other (please specify): Compliance with the Transparency Directive

No

3

Full name of the person subject to the notification obligation

Vanguard Healthcare Fund

4

Full name of shareholders

Vanguard Healthcare Fund

5

Date of the Transaction (and date on which the threshold crossed is reached differently)

8 February 2016

6

Date on which the issuer notified

10 February 2016

7

Threshold that is crossed

3%

8

Notified details

See A, B & C below

A. Voting rights attached to shares

Class type of shares (if possible using the ISIN code)

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

Number of voting rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

Ordinary Shares (0.10 GBP)

GB00B0LCW083

5,912,554

5,912,554

6,008,846

6,008,846

3.01%

B. Qualifying Financial instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration Date

Exercise/Conversion Period/Date

Number of voting rights that may be acquired if the instrument if exercised/converted

% of voting rights

-

-

-

-

-

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Exercise Price

Expiration Date

Exercise/Conversion Period/Date

Number of voting rights instrument refers to

% of voting rights

Nominal

Delta

-

-

-

-

-

-

-

Total A+B+C

Number of Voting rights

% of voting rights

6,008,846

3.01

9

Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable

Proxy Voting

10

Name of the proxy holder

N/A

11

Number of voting rights proxy holder will cease to hold:

12

Date on which proxy holder will cease to hold voting rights:

13

Additional Information

14

Contact name:

Vanguard Health Care Fund

c/o The Vanguard Group, Inc.

Vanguard_Fund_Compliance@Vanguard.com

15

Contact telephone number:

+001 (610) 669-8989